Precision radiation before surgery shows promise for rare abdominal tumor

NCT ID NCT01841047

Completed Disease control Sponsor: Institut Bergonié Source: ClinicalTrials.gov ↗

First seen Oct 31, 2025 · Last updated May 09, 2026 · Updated 28 times

Summary

This study tested a high-precision radiation treatment (helical tomotherapy) given before surgery for retroperitoneal liposarcoma, a rare cancer in the abdomen. The goal was to see if a higher radiation dose (54 Gy) could lower the chance of the cancer coming back. 48 adults with operable tumors took part. The approach aims to improve local control while limiting damage to nearby organs.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LIPOSARCOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Centre Claudius Regaud

Toulouse, Midi-Pyrénées, 31000, France
Centre Paul Strauss

Strasbourg, Alsace, 67000, France
Centre René Gauducheau

Nantes, Pays de la Loire Region, 44000, France
Institut Bergonié

Bordeaux, Aquitaine, 33000, France
Institut Curie

Paris, Île-de-France Region, 75000, France

Conditions

Explore the condition pages connected to this study.

LIPOSARCOMA